CPG1 Treatment of Symptoms of Menopause: An Endocrine Society Clinical Practice Guideline

Program: Clinical Practice Guidelines
Clinical Session
Thursday, March 5, 2015: 9:30 AM-10:30 AM
Hall G (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Corcept Therapeutics Incorporated, Noven Pharmaceuticals, Inc. and Pfizer, Inc.

Moderator:
Christopher Rolland McCartney, MD, University of Virginia Health System, Charlottesville, VA
Chair:
Cynthia A Stuenkel, MD, University of California, San Diego, La Jolla, CA
Task Force Participants:
Anne Gompel, MD, PHD, Hôpitaux Universitaires Paris Centre , Port Royal, Université Paris Descartes, Paris, France , Mary Ann Lumsden, BSc Hons, MB.BS, MRCOG, MD, FRCOG, University of Glasgow, Glasgow, United Kingdom , JoAnn V Pinkerton, MD, University of Virginia, Charlottesville, VA and Susan Ruth Davis, MBBS, FRACP, PhD, Monash University, Melbourne VIC, Australia

Disclosures:
JVP: Consultant, Pfizer, Inc., Consultant, TherapeuticsMD, Consultant, Noven, Consultant, Shionogi. SRD: Ad Hoc Consultant, Trimel Pharmaceuticals, Investigator, Lawley Pharmaceuticals. Nothing to Disclose: CAS, CRM, AG, MAL